Gemtuzumab Ozogamicin as Post-Consolidation Therapy does not prevent relapse in children with AML: Results of the NOPHO-AML 2094 Study
2011 (English)In: 53rd ASH Annual Meeting and Exposition, December 10-13, 2011 : Program: Oral and Poster AbstractsSession: 615. Acute Myeloid Leukemia - Therapy, excluding Transplantation: Poster I Saturday, December 10, 2011, 5:30 PM-7:30 PM Hall GH (San Diego Convention Center), 2011, Vol. 118, no 21, 667-667 p.Conference paper (Refereed)
Place, publisher, year, edition, pages
2011. Vol. 118, no 21, 667-667 p.
IdentifiersURN: urn:nbn:se:umu:diva-53140ISI: 000299597102129OAI: oai:DiVA.org:umu-53140DiVA: diva2:510031
53rd ASH Annual Meeting and Exposition, December 10-13, 2011